Sernova (XTER:PSH) Other Long-Term Liabilities : C$0.00 Mil (As of Jan. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Sernova Other Long-Term Liabilities?

Sernova's other long-term liabilities for the quarter that ended in Jan. 2024 was C$0.00 Mil.

Sernova's quarterly other long-term liabilities declined from Jul. 2023 (C$0.00 Mil) to Oct. 2023 (C$0.00 Mil) but then increased from Oct. 2023 (C$0.00 Mil) to Jan. 2024 (C$0.00 Mil).

Sernova's annual other long-term liabilities increased from Oct. 2021 (C$0.00 Mil) to Oct. 2022 (C$0.00 Mil) but then declined from Oct. 2022 (C$0.00 Mil) to Oct. 2023 (C$0.00 Mil).

Sernova Other Long-Term Liabilities Historical Data

The historical data trend for Sernova's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sernova Other Long-Term Liabilities Chart

Sernova Annual Data

Trend

Oct14

Oct15

Oct16

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Other Long-Term Liabilities

Get a 7-Day Free Trial

Sernova Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Other Long-Term Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Sernova Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Sernova Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Sernova's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Sernova (XTER:PSH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sernova Corp (XTER:PSH) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

SEOVF:USA PSH:Germany SVA:Canada

Address

700 Collip Circle, The Stiller Centre, Suite 114, London, ON, CAN, N6G 4X8

Website

https://www.sernova.com

Sernova Corp is a clinical-stage company developing products for the treatment of chronic debilitating diseases. The company is engaged in the research and development of its proprietary Cell Pouch and associated technologies including immune-protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device designed to create a vascularized tissue environment for the transplantation and engraftment of therapeutic cells, which then release proteins and or hormones for the long-term treatment of multiple serious, chronic diseases such as diabetes, hemophilia, and thyroid disease.